Ibuprofen
- Product NDC
- 21130-032
- 11-digit product format
- 211300032
- Labeler code
- 21130
- Product ID
- 21130-032_30a207f5-34a7-45ca-a1f8-5576b71c48d9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Better Living Brands LLC
- Application
- ANDA207753
- Marketing category
- ANDA
- Marketing start
- 2023-09-20
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibuprofen
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WK2XYI10QM |
| Rxcui | 310964 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21130-032 | IBUPROFEN CAPSULE [BETTER LIVING BRANDS LLC] | 2 | Current NDC, 6 package rows | 20230922_f6ef7f73-b5ab-4c82-e053-6394a90ac81e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 21130-032-12 | 21130003212 | 1 BOTTLE in 1 CARTON (21130-032-12) / 40 CAPSULE in 1 BOTTLE | 1 bottle | 2023-09-20 | No | No | Current |
| 21130-032-18 | 21130003218 | 1 BOTTLE in 1 CARTON (21130-032-18) / 80 CAPSULE in 1 BOTTLE | 1 bottle | 2023-09-20 | No | No | Current |
| 21130-032-32 | 21130003232 | 180 CAPSULE in 1 BOTTLE (21130-032-32) | 180 capsule | 2023-09-20 | No | No | Current |
| 21130-032-38 | 21130003238 | 300 CAPSULE in 1 BOTTLE (21130-032-38) | 300 capsule | 2023-09-20 | No | No | Current |